Exploring the Feasibility of a Telematic Version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS).

IF 2.8 3区医学 Q3 NEUROSCIENCES

Brain Sciences Pub Date : 2025-08-30 DOI:10.3390/brainsci15090948

Elisa Pini, Fulvio Pepe, Michelle Ingiardi, Veronica Laini, Nicoletta Ciccarelli, Eugenio Magni

{"title":"Exploring the Feasibility of a Telematic Version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS).","authors":"Elisa Pini, Fulvio Pepe, Michelle Ingiardi, Veronica Laini, Nicoletta Ciccarelli, Eugenio Magni","doi":"10.3390/brainsci15090948","DOIUrl":null,"url":null,"abstract":"Background/objectives: Parkinson's disease (PD) is a progressive neurodegenerative disorder frequently associated with cognitive impairment. In the context of increasing interest in remote healthcare solutions, particularly after the COVID-19 pandemic, this preliminary study aimed to evaluate the feasibility of an online version of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS), a first-level neuropsychological screening tool for mild cognitive impairment (MCI) in individuals with PD.Methods: Seventy-nine patients with idiopathic PD were recruited between October 2020 and February 2024. A telematic version of the PD-CRS was administered via video call using adapted materials (e.g., slide-based instructions and webcam-mediated tasks). Both patients and examiners completed a Visual Analogue Scale (VAS) to rate perceived difficulty. Descriptive statistics and non-parametric tests were used to analyze data.Results: Difficulty ratings were low for both patients (mean VAS = 1.60, SD = 0.88) and the examiner (mean VAS = 1.43, SD = 0.61), with no significant difference (p = 0.176). No demographic or clinical variable predicted difficulty.Conclusions: These findings support the feasibility and usability of an online version of PD-CRS. This approach may facilitate wider access to cognitive screening for PD patients, particularly those with mobility limitations or living in underserved areas.","PeriodicalId":9095,"journal":{"name":"Brain Sciences","volume":"15 9","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12467615/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/brainsci15090948","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}

引用次数: 0

Abstract

Background/objectives: Parkinson's disease (PD) is a progressive neurodegenerative disorder frequently associated with cognitive impairment. In the context of increasing interest in remote healthcare solutions, particularly after the COVID-19 pandemic, this preliminary study aimed to evaluate the feasibility of an online version of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS), a first-level neuropsychological screening tool for mild cognitive impairment (MCI) in individuals with PD.

Methods: Seventy-nine patients with idiopathic PD were recruited between October 2020 and February 2024. A telematic version of the PD-CRS was administered via video call using adapted materials (e.g., slide-based instructions and webcam-mediated tasks). Both patients and examiners completed a Visual Analogue Scale (VAS) to rate perceived difficulty. Descriptive statistics and non-parametric tests were used to analyze data.

Results: Difficulty ratings were low for both patients (mean VAS = 1.60, SD = 0.88) and the examiner (mean VAS = 1.43, SD = 0.61), with no significant difference (p = 0.176). No demographic or clinical variable predicted difficulty.

Conclusions: These findings support the feasibility and usability of an online version of PD-CRS. This approach may facilitate wider access to cognitive screening for PD patients, particularly those with mobility limitations or living in underserved areas.

查看原文本刊更多论文

探索远程信息处理版帕金森病认知评定量表（PD-CRS）的可行性。

背景/目的：帕金森病（PD）是一种进行性神经退行性疾病，常伴有认知障碍。在人们对远程医疗解决方案越来越感兴趣的背景下，特别是在COVID-19大流行之后，本初步研究旨在评估在线版帕金森病认知评定量表（PD- crs）的可行性，PD- crs是PD患者轻度认知障碍（MCI）的一级神经心理学筛查工具。方法：在2020年10月至2024年2月期间招募了79名特发性PD患者。PD-CRS的远程信息处理版本通过视频通话使用改编的材料（例如，基于幻灯片的指导和网络摄像头介导的任务）进行管理。患者和检查者都完成了视觉模拟量表（VAS）来评估感知困难。采用描述性统计和非参数检验对数据进行分析。结果：两组患者（平均VAS = 1.60, SD = 0.88）和检查者（平均VAS = 1.43, SD = 0.61）的难度评分均较低，差异无统计学意义（p = 0.176）。没有人口统计学或临床变量预测困难。结论：这些发现支持了PD-CRS在线版本的可行性和可用性。这种方法可能有助于更广泛地获得PD患者的认知筛查，特别是那些行动不便或生活在服务不足地区的患者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Brain Sciences Neuroscience-General Neuroscience

CiteScore

4.80

自引率

9.10%

发文量

1472

审稿时长

18.71 days

期刊介绍： Brain Sciences (ISSN 2076-3425) is a peer-reviewed scientific journal that publishes original articles, critical reviews, research notes and short communications in the areas of cognitive neuroscience, developmental neuroscience, molecular and cellular neuroscience, neural engineering, neuroimaging, neurolinguistics, neuropathy, systems neuroscience, and theoretical and computational neuroscience. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. Electronic files or software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.